NCT06200363 2024-01-11
A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer
West China Hospital
Phase 1 Unknown
Clinical Trials
11 trialsNCT02619435 2023-03-24
STREAM
National Cancer Institute, Naples
Phase 2 Unknown
NCT05495672 2022-08-10
Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules
Fudan University
Phase NA Unknown
NCT05035914 2021-09-05
Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal Cancer
Guangzhou University of Traditional Chinese Medicine
Phase 1/2 Unknown
NCT03126071 2021-08-30
Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT04324476 2021-08-30
A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT04929652 2021-06-18
Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
Phase 1/2 Unknown
NCT04252456 2020-02-05
DISTINCTIVE
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Phase NA Unknown
NCT02923622 2016-10-04
Efficacy and Safety Evaluation of Traditional Chinese Medicine in the Treatment of Advanced Colorectal Cancer
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Unknown
NCT00853684 2009-09-18
OXCE
Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT00972465 2009-09-07
Study of Nimotuzumab to Treat Colorectal Cancer
Peking University
Phase 2 Unknown